A new artificial intelligence tool called TxGNN has been developed to identify drug candidates for rare and undiagnosed diseases, of which there are over 7,000 globally. This tool aims to close the treatment gap for these conditions by repurposing existing drugs, offering hope for millions of people worldwide. TxGNN has identified drug candidates for over 17,000 diseases without existing treatments, showing promise in reducing the burden of disease. Its ability to predict patient characteristics and contraindications for treatments makes it an innovative and valuable tool in drug discovery. The researchers behind TxGNN are collaborating with rare disease foundations to further explore treatment options.
Source link
New AI tool revolutionizes drug discovery for rare diseases
